Institutional investors purchased a net $6.4 million shares of OPK during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 17.52% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 5.3 Million shares of OPKO Health Inc
GOLDMAN SACHS INTERNATIONAL Bought 1.0 Million shares of OPKO Health Inc
MENORA MIVTACHIM INSURANCE LTD. Bought 980.4 Thousand shares of OPKO Health Inc